title: Pulmonary toxicity secondary to procarbazine.
abstract: Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease. There are several side effects that it is commonly associated with; however, it has only rarely been reported to cause lung injury. The resulting pneumonitis may be severe and irreversible. There are eight reported cases in the literature. Here, we report another such case.
authors.affiliation: Upper Penninsula Hematology and Oncology Associates, Marquette, Michigan, USA.
authors.forename: Tallat
authors.initials: T
authors.lastname: Mahmood
authors.forename: Raja
authors.initials: R
authors.lastname: Mudad
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000009:adverse effects; D008875:Middle Aged; D011014:Pneumonia / Q000139:chemically induced* / Q000175:diagnosis; D011241:Prednisone / Q000009:adverse effects; D011344:Procarbazine / Q000009:adverse effects*; D014750:Vincristine / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone